Product Name:N-ethyl-N-methylsulfamoyl chloride

IUPAC Name:N-ethyl-N-methylsulfamoyl chloride

CAS:35856-61-2
Molecular Formula:C3H8ClNO2S
Purity:95%+
Catalog Number:CM737575
Molecular Weight:157.61

Packing Unit Available Stock Price($) Quantity
CM737575-5g in stock ǠŸǺ

For R&D use only.

Inquiry Form

   refresh    

Product Details

CAS NO:35856-61-2
Molecular Formula:C3H8ClNO2S
Melting Point:-
Smiles Code:CCN(C)S(Cl)(=O)=O
Density:
Catalog Number:CM737575
Molecular Weight:157.61
Boiling Point:
MDL No:MFCD11622866
Storage:

Category Infos

Aliphatic Chain Compounds
Aliphatic chain compounds include aliphatic compounds and chain compounds containing other elements or groups. Aliphatic hydrocarbons are hydrocarbons with the basic properties of aliphatic compounds. In aliphatic compounds, carbon atoms are arranged in straight chain, branched chain or cyclic, which are respectively called straight chain aliphatic hydrocarbons, branched chain aliphatic hydrocarbons and alicyclic hydrocarbons. Some cyclic hydrocarbons are different in nature from aromatic hydrocarbons, and are very similar to aliphatic hydrocarbons. Such cyclic hydrocarbons are called alicyclic hydrocarbons. In this way, aliphatic hydrocarbons become a general term for all hydrocarbons except aromatic hydrocarbons. Aliphatic hydrocarbons and their derivatives (including halogenated hydrocarbons) and alicyclic hydrocarbons and their derivatives are collectively referred to as aliphatic compounds.

Column Infos

Plixorafenib
FORE Biotherapeutics’s Plixorafenib (PLX-8394) is a next-generation, orally selective inhibitor and specific dimer breaker of BRAF protein under clinical development. Its favorable efficacy and tolerability are updated in the recently presented phase 1/2a results in BRAF V600 advanced solid tumors. Plixorafenib was designed to target a wide range of BRAF mutations while sparing wild type forms of RAF. It has been granted Fast Track Designation and Orphan Drug Designation from the U.S. FDA.